ASSAY and Drug Development Technologies
基本信息
ASSAY and Drug Development Technologies provides access to novel techniques and robust tools that enable critical advances in early-stage screening. This research published in the Journal leads to important therapeutics and platforms for drug discovery and development. This reputable peer-reviewed journal features original papers application-oriented technology reviews, topical issues on novel and burgeoning areas of research, and reports in methodology and technology application. ASSAY and Drug Development Technologies coverage includes: Assay design, target development, and high-throughput technologies Hit to Lead optimization and medicinal chemistry through preclinical candidate selection Lab automation, sample management, bioinformatics, data mining, virtual screening, and data analysis Approaches to assays configured for gene families, inherited, and infectious diseases Assays and strategies for adapting model organisms to drug discovery The use of stem cells as models of disease Translation of phenotypic outputs to target identification Exploration and mechanistic studies of the technical basis for assay and screening artifacts The Journal also features a dedicated Drug Repurposing, Rescue, and Repositioning (DRRR) section. These special peer-reviewed collections of papers present techniques and tools for finding new uses for approved drugs – particularly for disorders where no animal model, physiologic abnormality, biochemical pathway, or molecular target has been identified. This DRRR special section features original papers, application-oriented technology reviews, and reports in methodology and technology application to drug repurposing and redevelopment including: Designing assays and interpreting output to enable alternate drug target identification Pathway analysis and bioinformatics to identify and exploit drug promiscuity In silico technologies to identify alternate drug targets "Big Data" mining and side effect pattern analysis in clinical and healthcare repositories
CiteScore
学科 | 排名 | 百分位 |
---|---|---|
Pharmacology, Toxicology and PharmaceuticsDrug Discovery |
93 / 146 | 36% |
期刊统计
投稿信息
相关文献
Chemoproteomics-based target profiling of sinomenine reveals multiple protein regulators of inflammation
Lianguo Chen, Hong-jian Wang, Teng-fei Ji, Chong-Jing Zhang
DOI: 10.1039/D1CC01522B
Water-soluble pH-switchable cobalt complexes for aqueous symmetric redox flow batteries
Yuqiao Zhou
DOI: 10.1039/D0CC00383B
A hollow neuronal carbon skeleton with ultrahigh pyridinic N content as a self-supporting potassium-ion battery anode
Yongwen Sun, Ya Zhang, Zheng Xing, Denghu Wei, Quanchao Zhuang
DOI: 10.1039/C9SE00889F
Small size yet big action: a simple sulfate anion templated a discrete 78-nuclearity silver sulfur nanocluster with a multishell structure
Li-Ping Cheng, Zhi Wang, Qiao-Yu Wu, Hai-Feng Su, Tao Peng, Geng-Geng Luo, Yan-An Li, Di Sun, Lan-Sun Zheng
DOI: 10.1039/C8CC00014J
Biomaterials Science Emerging Investigators 2021
Maria E. Southall
DOI: 10.1039/D1BM90053F
Carbon-based photocatalysts for enhanced photocatalytic reduction of CO2 to solar fuels
Mufeedah Muringa Kandy
DOI: 10.1039/C9SE00827F
Microscopic insights into long-range 1D ordering in a dense semi-disordered molecular overlayer
Ryan T. Hannagan, Isaac Onyango, Amanda Larson, E. Charles H. Sykes
DOI: 10.1039/D1CC01574E
Synthesis and hydrogen evolving catalysis of a panchromatic photochemical molecular device
Johannes Habermehl, Djawed Nauroozi, Miłosz Martynow, Yury E. Vilk, Radim Beranek, Julien Guthmuller, Sven Rau
DOI: 10.1039/C9SE00304E
A model-based comparison of Ru and Ni catalysts for the Sabatier reaction
DOI: 10.1039/C9SE00787C